G0S2 and pancreatic neoplasm: At present, only one study on the bioinformatics analysis of 179 pancreatic cancer samples and 171 normal pancreatic tissue samples on the GEPIA platform revealed that G0S2 was identified as a lipid drop-related factor and was differentially expressed in PC samples (Bai et al. 2021).